← Back to Cancer ScreeningGuideline recommended
Oncotype DX
Breast cancer patients deciding on chemotherapy
Variable
Test Performance
Sensitivity
N/A
Specificity
N/A
Detection Method
Gene expression
Turnaround
10-14 days
Key Features
Predicts chemotherapy benefit • Recurrence risk score • Tumor tissue analysis • Guides treatment decisions
Who It's For
Important Notes
Not a screening test - analyzes existing tumor to guide treatment. Standard of care for ER+ breast cancer. Now part of Exact Sciences Precision Oncology.
Learn more about Oncotype DX
Discuss with your physician before ordering.
Visit Oncotype DXCompare All